Immunotherapy for advanced or relapsed cervical cancer

Cheng Tao Lin*, Chao Nin Wang, Chyong Huey Lai

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Cervical cancer is the third most commonly diagnosed cancer and the fourth leading cause of cancer deaths worldwide. Conventional approaches by surgery, radiotherapy, and/or chemotherapy cannot provide satisfied therapeutic outcomes for advanced or relapsed cervical cancer. Thus, immunotherapy or biotherapy for these patients has been the mode of treatment. A number of studies on immunotherapy for cervical cancer in animals has been published. This time, we summarized our experiences and concepts with regard to the therapeutic approach for advanced cervical cancer in humans.

Original languageEnglish
Pages (from-to)3-7
Number of pages5
JournalGynecology and Minimally Invasive Therapy
Issue number1
StatePublished - 02 2013


  • Biotherapy
  • Cervical cancer
  • Immunotherapy


Dive into the research topics of 'Immunotherapy for advanced or relapsed cervical cancer'. Together they form a unique fingerprint.

Cite this